Willach has opened the doors to its new $500,000 training facility in Burwood, east of Melbourne. The 1000sqm site is more than double the size of Willach’s previous premises in …

Recently the fifth IGCD Stakeholder Forum was held in Melbourne. Delegates from around Australia participated in discussions that would shape the policy on how we would manage drug use for …

PPA President, Dr Geoff March welcomed the announcement of pharmacy remuneration and regulation review panellists as an opportunity for employee pharmacists to shape the future of pharmacy. “Last night, the …

British GPs have labelled the UK’s pharmacy flu services as having a “chaotic” setup, reports Chemist+Druggist. The UK pharmacy magazine spoke to Royal College of General Practitioners president Maureen Baker …

The AMA is urging school leavers celebrating Schoolies Week around the country to ensure their celebrations are memorable for all the right reasons, national president Dr Stephen Parnis, says. Schoolies …

Gastro-oesophageal reflux disease and its treatments require evaluation of symptom control, writes Ben Basger The Royal Australian College of General Practitioners has recommended that doctors don’t use proton pump inhibitors …

New policies to be introduced by the Andrews Government are a welcome move to improve the health of Victorians by enabling better utilisation of the skills and expertise of pharmacists …

The Heart Foundation is calling for a renewed focus on prevention and acute care for Aboriginal and Torres Strait Islander peoples, in the wake of more damning data on chronic …

This week’s launch of Australia’s first ‘for-benefit’ pharmaceutical company is ushering in a new era of social enterprise that’s set to challenge the conventional for-profit pharma model, say stakeholders. For …

Tenders to deliver the Victorian Government’s Super Pharmacies Initiatives are now open, Victoria’s Minister for Health, Jill Hennessy, has announced. The initiative, to which the Andrews Government has pledged $28.7 …

Guidance for pharmacists and pharmacy staff on providing care for refugees has been issued by FIP. The advisory document, “Providing pharmaceutical care to migrant populations”, has been produced by an …

Pfizer today confirmed that the first mAb biosimilar, Inflectra (infliximab), will be added to the PBS on 1 December 2015 for the treatment of eight inflammatory conditions.